Abstract
Brain metastasis from papillary thyroid carcinoma (PTC) is extremely rare and carries a poor prognosis. We report nine cases (five females and four males) of brain metastasis of PTC. The age of patients ranged from 46 to 87 years old. The patients presented with nonspecific symptoms such as headaches. Brain metastasis was the first clinical presentation in three of nine patients; two of which had the aggressive tall cell variant of PTC. Six patients had prior history of PTC (four classic, one oncocytic variant, and one columnar cell variant) for 2 to 17 years with a median of 12 years. Gross total resection of brain metastasis was achieved for eight of our patients. Eight patients were treated with radioactive iodine. The median follow-up time was 12 months, ranging from 1 month to 4 years. Three patients died of their disease in 6 months, 21 months and 4 years, respectively after their first presentation of brain metastasis. It seems that these rare aggressive variants of PTC, such as tall cell variant, not only have higher propensity to develop brain metastasis, but also more frequently present with brain metastasis as their first clinical presentation than classic PTC. Furthermore, patients with PTC can develop brain metastasis even after many years.
Similar content being viewed by others
References
Hay ID, Thompson GB, Grant CS et al (2002) Papillary thyroid carcinoma managed at the Mayo Clinic during six decades (1940–1999): temporal trends in initial therapy and long-term outcome in 2444 consecutively treated patients. World J Surg 26:879–885
Pelizzo MR, Boschin IM, Toniato A et al (2007) Papillary thyroid carcinoma: 35-year outcome and prognostic factors in 1858 patients. Clin Nucl Med 32:440–444
Ibanez ML, Russell WO, Albores-Saavedra J et al (1966) Thyroid carcinoma—biologic behavior and mortality. Postmortem findings in 42 cases, including 27 in which the disease was fatal. Cancer 19:1039–1052
Carcangiu ML, Zampi G, Pupi A et al (1985) Papillary carcinoma of the thyroid. A clinicopathologic study of 241 cases treated at the University of Florence, Italy. Cancer 55:805–828
Parker LN, Wu SY, Kim DD et al (1986) Recurrence of papillary thyroid carcinoma presenting as a focal neurologic deficit. Arch Intern Med 146:1985–1987
McConahey WM, Hay ID, Woolner LB et al (1986) Papillary thyroid cancer treated at the Mayo Clinic, 1946 through 1970: initial manifestations, pathologic findings, therapy, and outcome. Mayo Clin Proc 61:978–996
Michie HR, O’Bryan-Tear CG, Marsh H et al (1987) Cerebral metastases from occult papillary carcinoma of the thyroid. Br J Surg 74:647–647
Goolden AW, Mclaughlin JE, Valentine AR et al (1990) Solitary cerebral metastasis from a papillary carcinoma of the thyroid. Postgrad Med J 66:127–129
Venkatesh S, Leavens ME, Samaan NA (1990) Brain metastases in patients with well-differentiated thyroid carcinoma: study of 11 cases. Eur J Surg Oncol 16:448–450
Yamamoto F, Maruiwa M, Kanetani K et al (1990) Coexistence of multiple metastatic brain tumors from thyroid carcinoma and cerebral aneurysms. No Shinkei Geka 18:361–365
Aihara N, Nagai H, Mase M et al (1991) Brain metastasis of thyroid papillary carcinoma—case report. Neurol Med Chir (Tokyo) 31:356–358
Biswal BM, Bal CS, Sandhu MS et al (1994) Management of intracranial metastases of differentiated carcinoma of thyroid. J Neurooncol 22:77–81
Hefer T, Joachims HZ, Hashmonai M et al (1995) Highly aggressive behaviour of occult papillary thyroid carcinoma. J Laryngol Otol 109:1109–1112
Jyothirmayi R, Edison J, Nayar PP et al (1995) Case report: brain metastases from papillary carcinoma thyroid. Br J Radiol 68:767–769
Honma Y, Kawakita K, Nagao S (1996) Intramedullary spinal cord and brain metastases from thyroid carcinoma detected 11 years after initial diagnosis—case report. Neurol Med Chir (Tokyo) 36:593–597
Altimari-Romero RA, Montenegro FL, Michaluart JP et al (1997) Brain metastases from papillary thyroid carcinoma: a case report and review of the literature. Rev Hosp Clin Fac Med Sao Paulo 52:263–266
Pacak K, Sweeney DC, Wartofsky L et al (1998) Solitary cerebellar metastasis from papillary thyroid carcinoma: a case report. Thyroid 8:327–335
Kapusta LR, Taylor M, Ang LC et al (1999) Cytologic diagnosis of a solitary brain metastasis from papillary carcinoma of the thyroid. A case report. Acta Cytol 43:432–434
Cha ST, Jarrahy R, Mathiesen RA et al (2000) Cerebellopontine angle metastasis from papillary carcinoma of the thyroid: case report and literature review. Surg Neurol 54:320–326
Maruyama M, Kobayashi S, Shingu K et al (2000) Solitary brain metastasis from papillary thyroid carcinoma in a patient with depression: report of a case. Surg Today 30:827–830
Imamura Y, Kasahara Y, Fukuda M et al (2000) Multiple brain metastases from a diffuse sclerosing variant of papillary carcinoma of the thyroid. Endocr Pathol 11:97–108
Aguiar PH, Agner C, Tavares FR et al (2001) Unusual brain metastases from papillary thyroid carcinoma: case report. Neurosurgery 49:1008–1013
Ota T, Bando Y, Hirai M (2001) Papillary carcinoma of the thyroid with distant metastases to the cerebrum: a case report. Jpn J Clin Oncol 31:112–115
Erem C, Hacihasanoglu A, Sari A et al (2004) Intrathyroideal papillary thyroid carcinoma presenting with a solitary brain metastasis. Endocrine 25:187–193
Pazaitou-Panayiotou K, Kaprara A, Chrisoulidou A et al (2005) Cerebellar metastasis as first metastasis from papillary thyroid carcinoma. Endocr J 52:653–657
Yousuf K, Archibald SD (2006) Brain metastases from papillary adenocarcinoma of the thyroid. J Otolaryngol 35:366–372
Al Dhahri SF, Al Amro AS, Al Shakwer W et al (2009) Cerebellar mass as a primary presentation of papillary thyroid carcinoma: case report and literature review. Head Neck Oncol 1:23
Diyora B, Nayak N, Kamble H et al (2010) Brain metastasis from papillary carcinoma of thyroid gland. J Neurosci Rural Pract 1:55–57
Miranda ER, Padrao EL, Silva BC (2010) Papillary thyroid carcinoma with brain metastases: an unusual 10-year-survival case. Thyroid 20:657–661
Xu YH, Song HJ, Qiu ZL et al (2011) Brain metastases with exceptional features from papillary thyroid carcinoma: report of three cases. Hell J Nucl Med 14:56–59
Chakrabarti I, Giri A, Majumdar K et al (2011) An unusual case of thyroid papillary carcinoma with solitary cerebral metastasis presenting with neurological symptoms. Turk Patoloji Derg 27:154–156
Asioli S, Erickson LA, Sebo TJ et al (2010) Papillary thyroid carcinoma with prominent hobnail features: a new aggressive variant of moderately differentiated papillary carcinoma. A clinicopathologic, immunohistochemical, and molecular study of eight cases. Am J Surg Pathol 34:44–52
Asioli S, Erickson LA, Righi A et al (2013) Papillary thyroid carcinoma with hobnail features: histopathologic criteria to predict aggressive behavior. Hum Pathol 44:320–328
Huang S, Hu Y, Huang Y et al (2004) Liver cavernous hemangioma mimicking metastatic thyroid carcinoma on 131I imaging: a case report and review of the literature. Ann Nucl Med Sci 17:179–183
Mazzaferri EL, Young RL, Oertel JE et al (1977) Papillary thyroid carcinoma: the impact of therapy in 576 patients. Med (Baltimore) 56:171–196
Hoie J, Stenwig AE, Kullmann G et al (1988) Distant metastases in papillary thyroid cancer. A review of 91 patients. Cancer 61:1–6
Lundgren CI, Hall P, Dickman PW et al (2006) Clinically significant prognostic factors for differentiated thyroid carcinoma: a population-based, nested case–control study. Cancer 106:524–531
Toniato A, Boschin I, Casara D et al (2008) Papillary thyroid carcinoma: factors influencing recurrence and survival. Ann Surg Oncol 15:1518–1522
Kim KM, Park JB, Bae KS et al (2012) Analysis of prognostic factors in patients with multiple recurrences of papillary thyroid carcinoma. Surg Oncol 21:185–190
Ito Y, KudoT KK et al (2012) Prognostic factors for recurrence of papillary thyroid carcinoma in the lymph nodes, lung, and bone: analysis of 5,768 patients with average 10-year follow-up. World J Surg 36:1274–1278
Van Nguyen K, Dilawari RA (1995) Predictive value of AMES scoring system in selection of extent of surgery in well differentiated carcinoma of thyroid. Am Surg 61:151–155
Pasieka JL, Zedenius J, Auer G et al (1992) Addition of nuclear DNA content to the AMES risk-group classification for papillary thyroid cancer. Surgery 112:1154–1159
Dean DS, Hay ID (2000) Prognostic indicators in differentiated thyroid carcinoma. Cancer Control 7:229–239
Acknowledgments
Cases 6–8 were presented as a poster at the 2008 American Association of Neuropathologist Annual Meeting at San Diego, California. Case 4 was published as a case report in Clinical Nuclear Medicine 35(5):357–359, 2010.
Conflict of interest
We declare that we have no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Tahmasebi, F.C., Farmer, P., Powell, S.Z. et al. Brain metastases from papillary thyroid carcinomas. Virchows Arch 462, 473–480 (2013). https://doi.org/10.1007/s00428-013-1394-4
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00428-013-1394-4